It is becoming more common to treat peripheral arterial diseases endovascularly with bare metal stents (BMS), often with high success rates. However, complications such as BMS infections do occur and have high morbidity (17.2e75.3%) and high mortality (32.5%). This study presents a case report of a BMS infection and an extensive review of literature of all BMS infections (coronary and peripheral) reported up to the present day. This review gives an insight into the risk factors, signs and symptoms, useful imaging techniques, treatment options, and (treatment-specific) mortality.
INTRODUCTION
Percutaneous transluminal angioplasty (PTA) with bare metal stent placement has become a very popular treatment modality for stenotic lesions, after being successfully introduced in humans in 1983. 1e3 The success is largely because of its minimally invasive character, rendering this an ideal treatment option for patients with multiple comorbidities. However, a stent infection is a rare complication with a high morbidity and high mortality, which may necessitate maximal invasive surgery. 4 The current study consists of a case report of a bare metal stent infection, which occurred in Rijnland Hospital, Leiderdorp, The Netherlands, when a stent was placed after prolonged thrombolysis (48 hours) through the same sheath, and of a systematic literature search, in which 76 additional cases of intravascular bare metal stent infections (coronary and peripheral) were identified. Risk factors, signs and symptoms, useful imaging techniques, treatment options, and mortality were identified and reported.
A 50-year-old woman without any significant comorbidities was admitted to the emergency department of Rijnland Hospital with a cold, pale, and painful left lower leg. She was woken by an acute onset of the pain, which also radiated to her back. Physical examination showed a pale lower leg without palpable pulsations of the dorsalis pedis or the posterior tibial artery. Weak pulsations were palpable over the popliteal and femoral artery, and capillary refill was prolonged (6 seconds). The patient was clinically diagnosed with an acute arterial occlusion and an angiogram was performed through a contralateral puncture in the right groin. It showed an occlusion of the left common iliac artery (CIA) reaching to the iliac bifurcation and a thrombus in external iliac artery (Fig. 1) . The popliteal artery was occluded by an embolus. The crural arteries were not visualized. Subsequently, a 6 Fr sheath was placed in a retrograde fashion in the left common femoral artery to recanalize the occlusion in the CIA and urokinase treatment was started (bolus 100.000 IE and continuous infusion 100.000 IE/h). The urokinase was sprayed in the thrombus through a valved infusion catheter (Cragg-McNamara Valved Infusion Catheter, EV3, Plymouth, MN, USA). After 24 hours a control angiogram was performed, which showed a successful recanalization of the occlusion in the left CIA with a persistent 40% stenosis over 4 cm length and a minimal embolism remaining in the popliteal artery (Fig. 2) . Thrombolysis was continued for another 24 hours.
Control angiogram, 48 hours after starting the thrombolytic therapy, showed a persistent 40% stenosis in the CIA and a successful thrombolysis of the iliac, popliteal artery and crural arteries. To prevent a new occlusion, a nitinol stent (S.M.A.R.T. Control nitinol stent; Cordis Corporation, Bridgewater, NJ, USA) was placed in the left CIA (Fig. 3) . After the placement of the stent, the sheath was removed and a pressure bandage was applied for 12 hours according to standard hospital protocol. The patient was discharged from the hospital the day after without any symptoms.
Four weeks later the patient was re-admitted with symptoms of tenderness in the left buttock and leg, a warm, slightly swollen left knee, and a fever (T 39 C). On the ventral side of her leg there were multiple petechiae. The inguinal area was unremarkable without hematoma or lymphadenopathy and peripheral pulsations were present. Her blood analysis showed a CRP of 248 mg/L, a leukocytosis of 14.2 Â 10 9 /L and a BSE of 68 mm/h. A septic arthritis of the knee was excluded through a synovial puncture by an orthopedic surgeon. After taking blood cultures, clinical treatment with intravenous antibiotics (cefuroxim 750 mg 3dd1, gentamycin 400 mg 1dd1) was started. During admission the diagnosis of endocarditis was excluded by a cardiologist via a transthoracic echocardiogram. The blood cultures showed Staphylococcus aureus, after which the antibiotics were changed to flucloxacillin 12g/24h. After a week, a PET-CT was performed which showed an infected mass around the stent in the left CIA (Fig. 4A, B) , a hydronephrosis of the left kidney caused by obstruction by the mass and no signs of further infection elsewhere. A standard CT-angiography (CTA) was performed, which confirmed a pseudoaneurysm with contrast leakage and the hydronephrosis (Fig. 4C) .
Following the diagnosis of the infected stent, the patient was planned for surgery. The hydronephrosis was treated by an urologist by placing a double-J ureteral catheter in the left ureter. During the operation, a femoralefemoral crossover bypass was created using a rifampicin-coated Dacron graft, after ligation of the external iliac artery. After installation of the crossover bypass, the left internal iliac artery and the left common iliac artery were ligated and the evidently infected common iliac artery and stent were excised. The culture of the stent was sterile, probably because of the long treatment with intravenous antibiotics.
The patient was discharged free of symptoms 1 week postoperatively. The intravenous antibiotic treatment was continued at home through a central venous catheter for another 5 weeks. A control duplex ultrasound showed a patent crossover bypass 6 weeks postoperatively, laboratory results showed a CRP of 3 mg/L, leukocytosis of 7.3 Â 10 9 /L and a BSE of 33 mm/h.
REVIEW OF LITERATURE

Methods
Following this case, a literature search was performed to identify similar cases of bare metal stent infections. We decided to include all bare metal stent infections in the vascular system and not to exclude coronary stents. A PubMed search was performed (Appendix I), in which we identified 1073 articles. A total of 68 articles were selected as intravascular bare metal stent infections by two independent investigators based on the abstracts. A further eight cases of bare metal stent infections were identified from references of the earlier found articles. As shown in Table 1 , we collected and analyzed 77 cases (29 coronary, 48 non-coronary) including our own. 4e73 We decided to present the data for the overall group, but also to subdivide into subcategories in coronary 8 (Tables 2 and 3 ).
Patient/case characteristics
From the selected case reports information was extracted about the vessel location in which the stent was placed and the patient condition (Table 2) . Per case an ASA-score was attributed, for as far as this was possible from the provided information. 74 It should be noted that the sum of the percentages in the vessel location column exceed 100%, as in some cases stents were placed in more than one vessel.
Risk factors and reasons of infection
The etiology of the infection for each individual case is complex and cannot always be verified. Table 4 shows the several risk factors for bare metal stent infections, according to the authors of the specific case reports.
In the present case, we believe that the placement of the stent through an indwelling sheath, in situ for over 48 hours, without the use of antibiotic prophylaxis, could be the reason for infection. Very similar cases have been described before. 13, 34 Furthermore it should be noted that in our case the stents were placed in an angiosuite, without optimal sterility, as, for example, it lacked an airtight preparation room and lamellar flow. Optimal sterility around stenting procedure is believed to be essential in the prevention of primary infection of stents. 13,15,16,20e22,26,30,70 It is often believed that sterility is not optimal when a stent is placed in an emergency setting; however, in 63.6% of reported cases, the infected stent was placed in an elective setting (Table 3) .
Pathophysiology
The exact pathophysiology of stent infections in the human situation remains unclear. The inflammatory processes consist of stent thrombosis, progressive arterial destruction, septic embolization, pseudoaneurysm formation, arterial disruption, and hemorrhage. 75 Several animal studies have been performed towards an enhanced insight.
75e77 Angioplasty leads to denudation of the endothelial lining of the vessel, which is aggravated by the metal struts of the stent, after which the arterial media is exposed to the bare metal struts. The bare metal stent itself can function as a nidus for bacterial adherence and colonization, after which sequesters of the bacteria may spread in the arterial wall, inducing inflammation, pseudoaneurysm, necrosis, and eventually rupture. The bare metal stent forms the ideal vector for the bacteria. 18,75e77 It is uncertain which process occurs first, infection prohibiting incorporation or poor incorporation leading to infection. 75 However, it appears that neointima formation serves as a protective measure against infection and that delayed bacterial challenge after arterial wall incorporation is less likely to result in infection. 4 This fact is underlined by the remarkable increase of reported infected coronary stents in the last decade: from the 24 coronary stent infection cases reported since 2003, 16 cases were with drug eluting stents (Tables  1  and  3 ). The drugs eluded by the stent were rapamycine, 43 sirolimus, 45, 53, 56, 57, 61, 69 paclitaxel, 44, 53, 54, 59, 72 and everolimus. 68 The local inflammation, which leads to neointimal growth (caused by proliferation of smooth muscle cells), neointimal hyperplasia, and eventually restenosis, is inhibited by the immunosuppressive effects of the drugs. 45, 57, 59, 69 However, this inhibition of neointimal growth may lead to the fact that metallic stents remain uncovered intraluminally, forming an ideal nidus for passing bacteria. 59, 72 This is underlined as in seven of the 16 cases the infection took place later then the first 4 weeks after stent placement (Table 1) . 53, 54, 57, 59, 61, 62, 72, 73 This relatively high infection rate is a concerning side effect of drug eluting stents, which cannot be neglected. Gonda et al. underline the fact that, given the large number of DES that are currently implanted worldwide, the problem may be more common than currently evident and thus physicians should be cognizant of this potential complication.
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Clinical presentation
The clinical presentation of a stent infection generally consists of aspecific symptoms such as fever, malaise, chills, leukocytosis and more specific symptoms such as local pain, local edema, and local skin symptoms (Table 5) . Typical occurring dermal symptoms are petechiae, rash, cellulitis, and edema. As many of the symptoms are aspecific, the diagnosis is one of exclusion, excluding other possible origins of bacteremia and fever. 4 Very often the diagnosis of an infected stent is missed in the first phase, with a subsequent delay in definitive treatment. The average time to definitive treatment of the infected stent was 16.4 days, and in one case a delay of 180 days was described. 30 Patients were often re-admitted to the clinic, without a clear focus of the infection. 15 In our case as well, the first differential diagnoses were endocarditis and septic arthritis. These were excluded after consultation with a cardiologist and an orthopedic surgeon. Although the average time to presentation is 161 days, in most cases (57.5%), the infection presents in the first month after stent placement (Table 5) . In ten cases, the infection presented itself more than a year after stent placement. 18, 36, 37, 41, 49, 60, 61, 66, 71, 72 In six of these late cases, the infection was probably caused by distal infected ulceration 41, 49, 60, 72 or a fresh surgical wound of a secondary intervention. 18, 37 In 50.7% of the reported cases, a delay in recognition of the stent infection was described. The average delay of recognition from the first symptom occurrence was 34.7 days, of which 1.4 days were patient delay and 33.4 days were doctor delay (Table 5 ). Patients should receive clear instructions to return to the clinic when these symptoms occur, as very often there is a patient delay, sometimes as high as 3 weeks. 30, 70 When a patient does return to the clinic with aspecific symptoms such as fever, chills, and malaise (Table 5) , the physicians should be alert for stentinfection, especially in the first month after stent placement.
Imaging studies
Several different imaging modalities are used for the diagnosis of stent-infection (Table 6 ). In several cases (18.8%) of infected peripheral stents, transesophageal echocardiograms were performed to exclude diagnosis of endocarditis. 10, 13, 29, 32, 34, 35, 41, 42, 71 The presence of a pseudoaneurysm is an important radiological sign indicating possible stent infection. In our review, we found that in 77.9% of the cases a pseudoaneurysm was described ( Table 5 ). Visualization of pseudoaneurysms was generally performed with a combination of ultrasound, and CT(A)s and even angiograms. 31 .0 a When the authors described their procedure as "standard" or "uncomplicated", we assumed that the catheter was removed with 6 hours of placement. To prove active infection, nuclear imaging such as WBC-scans 4, 12, 18, 25, 29, 32, 34, 47, 50, 57, 58, 62, 67, 68 and PETscans 67, 72 can be used. A WBC-scan was performed in 16 cases, of which 10 were true positive, and six were false negative (Table 7) . 18, 32, 34, 47, 57 However, in these false negative cases, other non-invasive imaging modalities used in the same patients were also inconclusive for the diagnosis in four cases. 18, 34, 47, 57 For example, in the case described by Kishida et al., the WBC-scan was performed 1 day after stent-placement, making it difficult to detect the infection already. 57 In our case, the stent infection was proved using a PET-CT scan (Fig. 4A, B) . Use of PET-CT had been described in only two other cases. 67, 72 In all three cases, the PET-CT was successful in identifying the stent-infections; however, the diagnosis could arguably also have been made with other imaging modalities performed at the same moment (Table 7) . Nevertheless, we believe the PET-CT is a very useful tool in diagnosis of an infected stent. In a prospective cohort study with retrospective analysis, the accuracy of FDG-PET-CT in detecting vascular prosthetic infections, was analyzed by Bruggink et al. 78 The PET-CT had a superior sensitivity (93% vs 56%) and specificity (70% vs 57%) when compared with CT. These findings were underlined in the review article of prosthetic graft infections by Legout et al. 79 
Treatment of infected stent
Infected endovascular stents pose difficult management problems. Successful conservative treatment with antibiotics has been described, 12, 14, 29, 31, 32, 47, 50 yet in up to 50.0% of cases it had a fatal outcome (Table 8) . 24, 28, 43, 61, 62, 73 It should be noted that in four of these fatal cases a surgical approach was preferred, but the patients were either unfit for surgery, or major surgery was refused by the patients. 28, 61, 62 When antibiotic therapy is the only treatment option, prescription of antibiotics such as daptomycin or rifampicin can be considered, as they diffuse in the potential biofilm of the stent. 79 ,80 Cunha et al. described a successful treatment of a bacterial endocarditis and coronary stent infection by high-dose daptomycin. 50 Similar to infected vascular prosthesis, a surgical approach is preferred. which consists of total removal of the infected material and subsequent installation of an extraanatomical or in situ bypass, preferably with autologous material. 79, 80 Surgical therapy was applied in 18 of the coronary cases and 40 of the non-coronary cases. Table 8 shows the surgical therapy as it was applied in the selected cases. The morbidity of the infected (non-coronary) stents is underlined by the high amputation rate and/or removal of viscera in 25.0% of patients. In the coronary group there was a high peri-procedural mortality of 16.7%. The overall mortality in the surgery group was 27.6%, with mortality up to 38.9% in the coronary group.
In selected cases an endovascular treatment of the stent infection was chosen. 18, 30, 56, 65 Bunt et al. chose to coil a pseudoaneurysm with coils, followed by above-knee amputation. 18 Garg et al. sealed a perforation of a mycotic aneurysm of the LAD, as the patient refused major surgery. 56 Tiesenhausen et al. excluded a pseudoaneurysm with a covered stent, which eventually became infected as well, requiring surgical excision. 30 Wu et al. treated a The potential sources of infection are stated in the left column, categorized for patient-related, procedure related, stent-related, and post-procedure related factors, while in the right column the cases numbers are noted in which the specific risk factor was the reason for infection according to the author of the case.
coronary pseudoaneurysm successfully with covered stent and antibiotics. 65 However, the mortality rate in these four cases was 75.0%. 18, 30, 56 The overall mortality, disregarding the type of treatment, of infected bare metal stents is very high: in the coronary group it was 48.3%, in the non-coronary group it was 22.9%, leading to an overall mortality of 32.5%. This underlines the importance of peri-procedural sterility and early recognition and adequate treatment, when the stent is infected.
Organism and prophylactic antibiotics
The organism responsible for the stent infection was a commensal skin bacterium in the majority (87.0%) of the included patients (Tables 1 and 2 ). In most cases (76.6%), the organism was Staphylococcus aureus, a part of which was methicillin resistant (MRSA). The large number of skincommensal bacteria infections underlines the theories of many authors that the infection takes place primarily and mostly peri-procedurally (Table 4 ). In 3.9% of the cases there was a non-bacterial infection: Liapis et al. described a mucormycosis-infection in a patient receiving immunosuppression after kidney-transplantation, 51 Bangher et al. showed a Candida infection in a diabetic patient, 40 while Raychaudhuri et al. found a fungus infection in a nonimmunocompromised 36-year-old after stenting of the basilar artery. 63 As previously stated, peri-procedure sterility is essential in preventing local skin infection and stent infection. Angiosuites are becoming comparable with operating rooms, with air-tight preparation rooms and lamellar flow and strict sterility protocols applied during stent placement. 81, 82 The use of prophylactic antibiotics remains a muchdiscussed topic. 4, 17, 32, 83 In only 13.0% of cases was administration of prophylactic antibiotics described, while in 40.3% of the cases it was clearly stated that antibiotics were not given. In the 10 patients who received prophylactic antibiotics, in only three cases had infection taken place in the first month. 8, 61, 69 In the other seven cases, the infection occurred at a later stage. 10, 28, 36, 41, 51, 53, 55 Although only 13.0% of the authors administered prophylactic antibiotics before stent placement, after having to treat a bare metal stent infection, 44.2% state in their discussions that they think there is a role for prophylactic antibiotics (Table 8) . In three cases, the authors state that the lack of prophylactic antibiotics was the reason for the bare metal stent infection (Table 4) . 22, 23, 27 Following the guidelines of the Society of Interventional Radiology, there is no indication for prophylactic antibiotics in case of standard placement of bare metal stents in lowrisk patients. 83 The main argument against prophylactic antibiotics is the large number of patients who would be treated to prevent bare metal stent infection, which would only have occurred in a few patients, 17, 32 and therefore the question arises of cost-effectiveness. 9 However, the major morbidity, necessitating major surgery, and the high mortality (32.5%) of the infections caused by bare metal stents may justify the use of prophylactic antibiotics such as cefazolin as most of the organisms were skin-commensals. Combining the information we have distilled from the review of literature (Tables 3, 5 and 8), we believe there is role for prophylactic antibiotics in selected cases:
Patients with immune deficiencies (high age, chronic renal impairment, DM, immunosuppressive medications). 17, 34, 83 Difficult procedures (i.e. multiple guide-wire exchanges, long procedure time, access site hematomas). Stenting of areas that are often re-punctured, for example hemodialysis catheters. 12, 83 Prolonged indwelling catheter (>6 hours), for example during thrombolysis. 33, 34, 83 Stenting of surgically difficult to reach areas or vessels (i.e. coronary, intra-thoracic, or intra-abdominal stents.) as surgical resection will have large morbidity and mortality. 35 Known colonization of the patient (pre-procedure noseswabs)
The guideline underlines that prophylactic antibiotics should be administered in cases in which there is a high risk of infection. 83 It remains unclear for how long the prophylactic antibiotics should be administered. Hogg et al. state that after bare metal stent placement a similar lifelong regimen to that of prosthetic heart valves, for example, should be followed. This means administration of prophylactic antibiotics before (dental) surgery, GI endoscopy, or other procedures that may facilitate bacteremia. 4 The animal study of Hearn et al. underlines the fact that an endovascular stent can easily be infected secondarily four weeks after stent placement. 77 However, as stated above, some studies show that the stents can be infected secondarily as a result of bacteremia even after more than a year. 18 Table 7 . The "true positive" and "false negative" findings of the nuclear imaging modalities, WBC-scan and PET-CT used in several cases.
WBC-Scan
PET-CT No cases used 16 3 True positive 10 3 Other concurrent non-invasive imaging negative
1
Other concurrent non-invasive imaging positive
2
False negative 6 0 Other concurrent non-invasive imaging negative
0
Other concurrent non-invasive imaging positive 2 0
Both categories are subdivided for other concurrent non-invasive imaging modalities (i.e. ultrasound, CT, MRI, X-ray) used in the same case for detecting the infected stent. The results in the subcategories of the emergency surgery are percentages of the number of patients who underwent surgery (overall n ¼ 58, non-coronary n ¼ 40, coronary n ¼ 18). The mortality numbers were a percentage of the overall group and of the treatment subgroups (surgery, endovascular exclusion, or only antibiotics).
CONCLUSIONS
An ever increasing number of endovascular procedures such as thrombolysis and bare metal stenting are performed in patients with multiple comorbidities. Although a rare complication, bare metal vascular stent infection does occur. Treatments of stent infections are procedures with very high morbidity and mortality (Tables 1 and 8 ). Therefore there is a need for a major effort to reduce the risk of infection of the foreign materials we place in these patients. Introduction in an absolute aseptic environment, use of an aseptic technique, and use of prophylactic antibiotics in selected patients should be pursued. In the presented case a bare metal stent was placed through a sheath left in situ for 48 hours because of thrombolysis, a situation which is not preferable. If we were confronted with a similar case in future, we would remove the initial sheath and place a new sheath under sterile conditions in the contralateral groin after administering prophylactic antibiotics. The relatively high number of infections with drug eluting stents is concerning, and needs further investigation. Medical physicians should always be suspicious of a stent infection when patients present with aspecific symptoms such as fever and chills after stent placement (Table 5) , and use imaging to see if a pseudoaneurysm is present. We believe a PET-CT is an ideal medium for the identification of a stent infection.
